Overview

Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects

Status:
Completed
Trial end date:
2013-12-09
Target enrollment:
Participant gender:
Summary
This early phase 1 study explored the brain uptake, retention, and safety of flortaucipir and obtained preliminary information regarding dosimetry of flortaucipir.
Phase:
Early Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals